Aldena Therapeutics and Empa Awarded InnoSuisse Funding to Advance STAR Particles as a Novel Drug Delivery Technology for Dermatology ...Middle East

BOSTON, April 26, 2023 /PRNewswire/ -- Aldena Therapeutics Inc. (Aldena), a private biotech company pioneering siRNA-based therapies for dermatological indications, and Empa, the Swiss Federal research institute for materials science and technology, have been awarded a joint 600'000 CHF...

Hence then, the article about aldena therapeutics and empa awarded innosuisse funding to advance star particles as a novel drug delivery technology for dermatology was published today ( Wednesday 26/04/2023 - 10:40 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Aldena Therapeutics and Empa Awarded InnoSuisse Funding to Advance STAR Particles as a Novel Drug Delivery Technology for Dermatology )

Also on site :

• Scott Ritter say he was ‘de-banked’
• Germany’s Merz changes stance on Russia
• Tokyo's Yamanote Line suspended due to power outage